Michael Clearfield
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Surgery top 0.2%
- Lipoproteins and Cardiovascular Health
Papers in
- Surgery 37
- Lipoproteins and Cardiovascular Health 34
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 14
- Hormonal Regulation and Hypertension 3
- Co-authors
- Antonio M. Gotto (12 shared papers)John R. Downs (10 shared papers)Stephen E. Weis (11 shared papers)Polly A. Beere (7 shared papers)Deborah R. Shapiro (7 shared papers)Edwin J. Whitney (7 shared papers)Alexandra Langendörfer (6 shared papers)Paul M. Ridker (5 shared papers)
- Journals
- Current Atherosclerosis Reports (10 papers)The American Journal of Cardiology (6 papers)The Journal of the American Osteopathic Association (2 papers)Circulation (2 papers)JAMA (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Michael Clearfield
60 papers receiving 8.1k citations
Michael Clearfield's Hit Papers
Peers
Comparison fields: 5 of 132
- Endocrinology, Diabetes and Metabolism 2.3k
- Surgery 4.7k
- Cardiology and Cardiovascular Medicine 1.5k
- Cancer Research 966
- Immunology 733
Countries citing papers authored by Michael Clearfield
This map shows the geographic impact of Michael Clearfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Clearfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Clearfield more than expected).
Fields of papers citing papers by Michael Clearfield
This network shows the impact of papers produced by Michael Clearfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Clearfield. The network helps show where Michael Clearfield may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Clearfield, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels Hit paper breakdown → | 1998 | 4058 |
| 2 | Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events Hit paper breakdown → | 2001 | 1241 |
| 3 | Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events Hit paper breakdown → | 2001 | 638 |
| 4 | Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins Hit paper breakdown → | 2012 | 582 |
| 5 | 2000 | 435 | |
| 6 | 2004 | 421 | |
| 7 | 2013 | 282 | |
| 8 | C-reactive protein: a new risk assessment tool for cardiovascular disease. | 2005 | 131 |
| 9 | 2001 | 99 | |
| 10 | 2001 | 76 | |
| 11 | 2006 | 68 | |
| 12 | 1997 | 63 | |
| 13 | 2002 | 52 | |
| 14 | 2009 | 47 | |
| 15 | 2009 | 42 | |
| 16 | Hemodynamic effects of osteopathic manipulative treatment immediately after coronary artery bypass graft surgery. | 2005 | 31 |
| 17 | 1994 | 27 | |
| 18 | 2000 | 27 | |
| 19 | 2017 | 25 | |
| 20 | 2005 | 22 |
About Michael Clearfield
Michael Clearfield is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism, Economics and Econometrics, Epidemiology and Cardiology and Cardiovascular Medicine, having authored 64 papers that have together received 8.6k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (34 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers), Cardiac, Anesthesia and Surgical Outcomes (3 papers), Pharmaceutical Economics and Policy (3 papers), Hormonal Regulation and Hypertension (3 papers) and Global Public Health Policies and Epidemiology (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.3k citations), Surgery (4.7k citations), Cardiology and Cardiovascular Medicine (1.5k citations), Cancer Research (966 citations) and Immunology (733 citations). Michael Clearfield has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Antonio M. Gotto, John R. Downs, Stephen E. Weis, Polly A. Beere, Deborah R. Shapiro, Edwin J. Whitney, Alexandra Langendörfer, Paul M. Ridker, Evan A. Stein and William B. Kruyer. Their work appears in journals such as Current Atherosclerosis Reports, The American Journal of Cardiology, The Journal of the American Osteopathic Association, Circulation and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.